logo-loader
viewUber Technologies Inc

Uber safety report shows more than 3,000 instances of reported sexual assault, shares slip

Uber's report noted that passengers aren’t the only ones facing risks but that nearly all the incidents were reported by women

Uber driver holding smartphone in car
Overall, Uber said, 99.9% of its 2.3 billion US rides in 2017 and 2018 were completed without incident

Uber Technologies Inc (NYSE:UBER) stock slid after the company’s first biennial US safety report revealed more than 3,000 reports of sexual assaults on 1.3 billion rides last year. 

The 84-page report, released Thursday, actually showed a 16% decrease in the five most serious categories of sexual assault reported from last year, according to a report from Reuters

The ride-sharing company saw shares fall 2.3% overnight to $27.98. 

READ: Uber rival Bolt sees London passenger numbers surge 400%

Specifically, the document revealed 235 instances of “non-consensual sexual penetration” and 280 of “attempted non-consensual sexual penetration.” Uber's report noted that passengers aren’t the only ones facing risks but that nearly all the incidents were reported by women.

Overall, Uber said, 99.9% of its 2.3 billion US rides in 2017 and 2018 were completed without incident. 

The release of the report comes less than two weeks after regulators in London cited a “pattern of failure” on the part of the company and denied it a new license to operate in the city.

Contact Andrew Kessel at [email protected] 

Follow him on Twitter @andrew_kessel

Quick facts: Uber Technologies Inc

Price: 35.13 USD

NYSE:UBER
Market: NYSE
Market Cap: $59.93 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Revenue guidance from OptiBiotix as it eyes NASDAQ listing

OptiBiotix Health (LON:OPTI) provides a commercial progress update, explaining why in their financials some items are separated. CEO Stephen O'Hara tells Proactive London what's behind his thinking adding that Optibiotix hopes to reach profitability in 2020. News here too on Sweetbiotix and...

1 day, 16 hours ago

2 min read